Skip to main content
NIH funding notice PAR-16-212

Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment (R01)

Closed on January 23, 2018.

Posted
April 21, 2016
Close date
January 23, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,042,888 in first-year total cost, median $521,444.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 BDCN-J (55)]2

Most frequent institutions

  1. SLOAN-KETTERING INST CAN RESEARCH1
  2. YALE UNIVERSITY1
Competing awards under PAR-16-212 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Assessment of sensory gating, attention, and executive control in breast cancer1R01CA218496-01A1AHLES, TIM ALANROOT, JAMES CSLOAN-KETTERING INST CAN RESEARCH, NY$687,576ZRG1
2018Neurocognitive Changes from Long-Term Androgen Deprivation Therapy in Prostate Cancer Patients1R01CA218501-01A1CHAO, HERTA HUEY-ANYALE UNIVERSITY, CT$355,312ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-16-212: Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment (R01) | ScienceDex | ConductScience